Belite Bio, Inc. (BLTE)

150.83 -7.53 (-4.75%) USD  |  NASDAQ  |  Jan 12, 11:45
More

Belite Bio Net Common Equity Issued (Purchased) (Annual)

Net Common Equity Issued (Purchased) (Annual) Chart

View Net Common Equity Issued (Purchased) (Annual) for BLTE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Net Common Equity Issued (Purchased) (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years

View Net Common Equity Issued (Purchased) (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Net Common Equity Issued (Purchased) (Annual) Benchmarks

View Net Common Equity Issued (Purchased) (Annual) Benchmarks
Start Trial
Ocugen, Inc. Upgrade
Ionis Pharmaceuticals, Inc. Upgrade
Ligand Pharmaceuticals, Inc. Upgrade
IDEAYA Biosciences, Inc. Upgrade
Terns Pharmaceuticals, Inc. Upgrade